10.01.13
Carlsbad, Calif.-based Aurora Spine Corporation has seen the first European implantation of its ZIP MIS (minimally invasive surgery) interspinous implant, performed at the Casa di Cura Rugani in Sienna Italy. The procedure was performed by Daniel Cabezas, M.D., a neurosurgeon with expertise in MIS spine surgery. Daniel Cabezas is a professor at the University of Rome Tor Vergata.
“We are pleased to begin commercialization of the Aurora ZIP mis interspinous fusion system in Europe and would like to thank Daniel Cabezas for performing the procedure,” said Trent J. Northcutt, president and CEO of Aurora Spine. “Over the remainder of the year we will train additional spine surgeons on our technology, which will support a broader launch in Europe beginning in 2014. We passionately believe the ZIP MIS interspinous fusion systems represents a significant opportunity to provide a better spinal fusion option for doctors, hospital systems and patients globally, and that it will be a growth driver for the company.”
The ZIP is a minimally invasive spinal fixation device for spinal fusion and was developed as an alternative to pedicle screw fixation. The system is designed for stabilization during T1-S1 lumbar fusion procedures specifically for the treatment of degenerative disc disease, spondylolisthesis, spinal tumors and trauma. The ZIP has locking mechanism that is meant to eliminate the use of a set screw, and comes in various sizes to accommodate different sized anatomy.
The ZIP MIS system is CE marked for sale in Europe, and is awaiting clearance from the U.S. Food and Drug Administration.
Aurora Spine is an early stage company that makes minimally invasive, regenerative spinal implant technologies.
“We are pleased to begin commercialization of the Aurora ZIP mis interspinous fusion system in Europe and would like to thank Daniel Cabezas for performing the procedure,” said Trent J. Northcutt, president and CEO of Aurora Spine. “Over the remainder of the year we will train additional spine surgeons on our technology, which will support a broader launch in Europe beginning in 2014. We passionately believe the ZIP MIS interspinous fusion systems represents a significant opportunity to provide a better spinal fusion option for doctors, hospital systems and patients globally, and that it will be a growth driver for the company.”
The ZIP is a minimally invasive spinal fixation device for spinal fusion and was developed as an alternative to pedicle screw fixation. The system is designed for stabilization during T1-S1 lumbar fusion procedures specifically for the treatment of degenerative disc disease, spondylolisthesis, spinal tumors and trauma. The ZIP has locking mechanism that is meant to eliminate the use of a set screw, and comes in various sizes to accommodate different sized anatomy.
The ZIP MIS system is CE marked for sale in Europe, and is awaiting clearance from the U.S. Food and Drug Administration.
Aurora Spine is an early stage company that makes minimally invasive, regenerative spinal implant technologies.